NL7812164A - Werkwijze voor het behandelen van hypertensie en daarop betrekking hebbende geneesmiddelen. - Google Patents

Werkwijze voor het behandelen van hypertensie en daarop betrekking hebbende geneesmiddelen.

Info

Publication number
NL7812164A
NL7812164A NL7812164A NL7812164A NL7812164A NL 7812164 A NL7812164 A NL 7812164A NL 7812164 A NL7812164 A NL 7812164A NL 7812164 A NL7812164 A NL 7812164A NL 7812164 A NL7812164 A NL 7812164A
Authority
NL
Netherlands
Prior art keywords
treating hypertension
related medicines
medicines
hypertension
treating
Prior art date
Application number
NL7812164A
Other languages
English (en)
Other versions
NL192870B (nl
NL192870C (nl
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7812164(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL7812164A publication Critical patent/NL7812164A/nl
Publication of NL192870B publication Critical patent/NL192870B/nl
Application granted granted Critical
Publication of NL192870C publication Critical patent/NL192870C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7812164A 1977-12-27 1978-12-14 Anti-hypertensief oraal farmaceutisch preparaat. NL192870C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27
US86442877 1977-12-27

Publications (3)

Publication Number Publication Date
NL7812164A true NL7812164A (nl) 1979-06-29
NL192870B NL192870B (nl) 1997-12-01
NL192870C NL192870C (nl) 1998-04-02

Family

ID=25343256

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7812164A NL192870C (nl) 1977-12-27 1978-12-14 Anti-hypertensief oraal farmaceutisch preparaat.
NL980017C NL980017I1 (nl) 1977-12-27 1998-04-24 Anti-hypertensief oraal farmaceutisch preparaat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL980017C NL980017I1 (nl) 1977-12-27 1998-04-24 Anti-hypertensief oraal farmaceutisch preparaat.

Country Status (30)

Country Link
JP (1) JPS54110333A (nl)
AR (1) AR230378A1 (nl)
AU (1) AU526239B2 (nl)
BE (1) BE873092A (nl)
CA (1) CA1120400A (nl)
CH (1) CH642542A5 (nl)
DE (1) DE2854316C3 (nl)
DK (1) DK578778A (nl)
EG (1) EG14178A (nl)
FI (1) FI783991A (nl)
FR (1) FR2413089A1 (nl)
GB (1) GB2010675B (nl)
GR (1) GR72951B (nl)
HK (1) HK45483A (nl)
HU (1) HU178747B (nl)
IE (1) IE48306B1 (nl)
IL (1) IL56281A (nl)
IT (1) IT1202811B (nl)
KE (1) KE3235A (nl)
LU (1) LU80709A1 (nl)
MY (2) MY8300240A (nl)
NL (2) NL192870C (nl)
NO (1) NO784357L (nl)
NZ (1) NZ189159A (nl)
PH (1) PH22111A (nl)
PL (1) PL212188A1 (nl)
PT (1) PT68983A (nl)
SE (1) SE445173B (nl)
SG (1) SG41482G (nl)
ZA (1) ZA786948B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
GB2010675A (en) 1979-07-04
IE782413L (en) 1979-06-27
FR2413089A1 (fr) 1979-07-27
PT68983A (en) 1979-01-01
EG14178A (en) 1984-06-30
BE873092A (fr) 1979-06-27
DE2854316C3 (de) 1994-12-22
HU178747B (en) 1982-06-28
PH22111A (en) 1988-06-01
AU4204178A (en) 1979-07-05
PL212188A1 (nl) 1980-02-11
GB2010675B (en) 1982-06-16
NZ189159A (en) 1984-12-14
HK45483A (en) 1983-10-28
IE48306B1 (en) 1984-12-12
SG41482G (en) 1985-01-11
DK578778A (da) 1979-06-28
JPS647045B2 (nl) 1989-02-07
NL192870B (nl) 1997-12-01
IL56281A0 (en) 1979-03-12
CH642542A5 (de) 1984-04-30
SE445173B (sv) 1986-06-09
JPS54110333A (en) 1979-08-29
CA1120400A (en) 1982-03-23
NO784357L (no) 1979-06-28
DE2854316C2 (nl) 1989-08-10
FR2413089B1 (nl) 1980-12-26
SE7813277L (sv) 1979-06-28
ZA786948B (en) 1980-04-30
IT7831266A0 (it) 1978-12-22
AR230378A1 (es) 1984-04-30
IT1202811B (it) 1989-02-09
KE3235A (en) 1982-11-05
NL980017I1 (nl) 1998-07-01
AU526239B2 (en) 1982-12-23
NL192870C (nl) 1998-04-02
IL56281A (en) 1983-05-15
DE2854316A1 (de) 1979-07-05
MY8300240A (en) 1983-12-31
FI783991A (fi) 1979-06-28
LU80709A1 (de) 1979-04-13
GR72951B (nl) 1984-01-17
MY102991A (en) 1993-03-31

Similar Documents

Publication Publication Date Title
NL7811183A (nl) Werkwijze en gas voor het behandelen van halfgeleiders.
NL7610795A (nl) Inrichting en werkwijze voor het behandelen van oppervlakken.
NL7703708A (nl) Werkwijze voor het behandelen van polyvinylideen- fluoride.
NL7810312A (nl) Werkwijze en materiaal voor het behandelen van weef- sels.
NL7806676A (nl) Inrichting voor het palettiseren en ontpalettiseren.
NL7710897A (nl) Werkwijze en inrichting voor het oprichten van koepelvormige bouwconstructies.
NL7808357A (nl) Werkwijze en inrichting voor het behandelen van gas.
NL7802646A (nl) Werkwijze en apparaat voor het met plasma be- handelen van halfgeleidermaterialen.
NL7809811A (nl) Werkwijze en inrichting voor het verbranden van kool- stofhoudende brandstof.
NL7703591A (nl) Werkwijze en inrichting voor het bekleden van onderdelen.
NL7810767A (nl) Werkwijze en inrichting voor het collationeren van documenten.
NL7706621A (nl) Werkwijze en inrichting voor het behandelen van vezelachtige materialen.
NL7808613A (nl) Micro-bollen en werkwijze voor het vervaardigen van de- ze micro-bollen.
NL7807687A (nl) Werkwijze en inrichting voor het verwijderen van ge- deelten uit vlak materiaal.
NL7602690A (nl) Werkwijze en inrichting voor het uitvoeren van coronaontladingsreacties.
NL7809596A (nl) Werkwijze voor het verankeren van elementen en inrich- ting ter uitvoering van deze werkwijze.
NL7802828A (nl) Werkwijze en inrichting voor het dopen van halfgeleidermaterialen.
NL7704726A (nl) Werkwijze en inrichting voor het voorverhitten van cokes.
NL7812164A (nl) Werkwijze voor het behandelen van hypertensie en daarop betrekking hebbende geneesmiddelen.
NL7801340A (nl) Werkwijze en inrichting voor het bereiden van kooks.
NL7712019A (nl) Werkwijze voor het behandelen van salpeterzuur- bevattende affluenten.
NL7810825A (nl) Werkwijze en systeem voor het bewerken van arabische-farsitalen.
NL7812365A (nl) Werkwijze en inrichting voor het vervaardigen van houders.
NL7701902A (nl) Werkwijze en inrichting voor het behandelen van de binnenzijde van buizen en buisleidingen.
NL7806696A (nl) Werkwijze voor het karakteriseren van kristallen.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
AC1 Application for a supplementary protection certificate

Free format text: 980017, 980424

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 980017

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 980017

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 981214